Kumaran Hospitals Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
as on 16-11-2024
- Paid Up Capital ₹ 4.00 M
as on 16-11-2024
- Company Age 35 Year, 8 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 5.10 Cr
as on 16-11-2024
- Revenue -19.68%
(FY 2023)
- Profit -40.46%
(FY 2023)
- Ebitda -234.85%
(FY 2023)
- Net Worth 8.66%
(FY 2023)
- Total Assets 10.10%
(FY 2023)
About Kumaran Hospitals
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 4.00 M.
The company currently has active open charges totaling ₹5.10 Cr.
Palanisamy Shivakumar, Palanisamy Manimekalai, Subbaiyan Palanisamy, and One other member serve as directors at the Company.
- CIN/LLPIN
U85110TN1989PTC017382
- Company No.
017382
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
05 May 1989
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Chennai
Industry
Company Details
- Location
Chennai, Tamil Nadu, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Kumaran Hospitals?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Subbaiyan Palanisamy  | Managing Director | 12-May-1989 | Current |
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Palanisamy Shivakumar | Director | 16-Dec-1992 | Current |
| Palanisamy Manimekalai | Director | 12-May-1989 | Current |
| Nithya Sekaran | Director | 02-Apr-2009 | Current |
Financial Performance of Kumaran Hospitals.
Kumaran Hospitals Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 19.68% decrease. The company also saw a substantial fall in profitability, with a 40.46% decrease in profit. The company's net worth moved up by a moderate rise of 8.66%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Kumaran Hospitals?
In 2023, Kumaran Hospitals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 26 Jun 2019 | ₹5.00 M | Open |
Corporation Bank Creation Date: 20 Nov 2013 | ₹1.00 M | Open |
Axis Bank Limited Creation Date: 28 Mar 2011 | ₹3.20 Cr | Open |
How Many Employees Work at Kumaran Hospitals?
Unlock and access historical data on people associated with Kumaran Hospitals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Kumaran Hospitals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Kumaran Hospitals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
